China has pulled ahead of the United States in key areas of the life sciences, and the U.S. may only have a handful of years ...

The current macro environment appears grim, given the uncertainty around the global trade war, along with ongoing ...

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ to discuss investing in biotech and the oversaturation in the sector. He said that looking at ...

Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...

Shares of early-stage biotech stocks, including Biohaven ( BHVN -6.50%), Recursion Pharmaceuticals ( RXRX -7.37%), and CRISPR ...

Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...

BioPharma Credit (LSE: BPCR) is one of the more esoteric investment trusts listed in London. Biotech is a specialist sector ...

Omega Funds founder and managing director Otello Stampacchia isn’t afraid to tell it like he sees it.

Biotech stocks had a bad week after turmoil at the FDA, continuing a long period of underperformance after the pandemic. Many ...

Although President Donald Trump’s “Liberation Day” tariffs have spared pharmaceuticals, potential drug-specific import taxes ...

Learn more about the biotech and biopharma industry in Europe, including market trends, investments, fundraisings, M&A, and ...